Andrew Lewis is in business development at Jazz Pharmaceuticals. Prior, he worked at Kairos leading deals from sourcing to close spanning all areas of the life sciences. He sits on the board of portfolio companies, manages partnerships with Cornell University, New York University, and Northwestern University, and will be serving as a reviewer for the NSF and NCI. Lewis is the first graduate of KGI to earn a position in venture capital directly following graduation.
Prior to Kairos, Lewis worked for Amgen in their Operations Leadership Program and consulting for Edwards Lifesciences. He also has several years of experience working in industry-partnered academic laboratories on collaborations with Abbott Laboratories, AstraZeneca, Bristol Myer Squibb, and British Petroleum on topics including drug discovery, neuroimaging, diagnostics, and biofuels.
Lewis holds an MBS degree from KGI and a BS degree from the University of Illinois in Molecular Biology, Psychology, and Philosophy. He also holds a certificate in Bioscience Industry Intellectual Property and Patent Law from Southwestern University.
Lewis has been actively engaged in the KGI community both as a student and alumnus. During his tenure as a student, he held the positions of Industry Ambassador, Intellectual Property and Technology Transfer Analyst; Vice President of the Consulting Club; Vice President of the Investing Club; Research Assistant to Dr. Joel West; and Student Mentor. Upon graduating, he continued his efforts to support and enrich the KGI environment by providing routine one-on-one mentoring to five students, all of whom earned top-tier internships, advising to KGI faculty seeking to raise seed funding, participating in KGI marketing videos, and was an invited lecturer presenting on the topic of Venture Capital. Lewis is very dedicated to supporting KGI as it grows and he seeks to continue providing value to KGI as a member of the Advisory Council.